CT-1578

N/A

Report date: 2023/01/12 17:31:44
NME

Base Information

Drug NameCT-1578
Drug Alias NameCT-1578SB-1578ONX-0805
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK2 inhibitorsTyrosine-protein kinase receptor FLT3 inhibitors
TargetsTyrosine-protein kinase JAK2Tyrosine-protein kinase receptor FLT3
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesS*BIO Pte Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesS*BIO Pte Ltd
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A